Methylchloroisothiazolinone and/or methylisothiazolinone in cosmetic products—A market survey
(2019) In Contact Dermatitis 80(2). p.110-113- Abstract
Background: There was a global epidemic of methylchloroisothiazolinone (MCI) and/or methylisothiazolinone (MI) contact allergy from 2009 to 2015. In response, the Thai Ministry of Public Health regulated the use of MCI/MI in cosmetics. Objective: To survey the presence of MCI/MI and MI alone, as labelled on cosmetics sold on the Thai market, before and after the ministerial directive. Methods: The presence of MCI and/or MI in leave-on and rinse-off cosmetics sold on the market, based on the labelling of ingredients in 3445 products, was analysed. Results: Before the implementation date, most leave-on products contained MCI/MI. After the regulations came into force, the only leave-on cosmetic subcategories that complied with the law were... (More)
Background: There was a global epidemic of methylchloroisothiazolinone (MCI) and/or methylisothiazolinone (MI) contact allergy from 2009 to 2015. In response, the Thai Ministry of Public Health regulated the use of MCI/MI in cosmetics. Objective: To survey the presence of MCI/MI and MI alone, as labelled on cosmetics sold on the Thai market, before and after the ministerial directive. Methods: The presence of MCI and/or MI in leave-on and rinse-off cosmetics sold on the market, based on the labelling of ingredients in 3445 products, was analysed. Results: Before the implementation date, most leave-on products contained MCI/MI. After the regulations came into force, the only leave-on cosmetic subcategories that complied with the law were facial skin-care, sunscreen and make-up products. MCI/MI and MI alone were found on the labels of both leave-on and rinse-off products, the presence of each varying between product subcategories. Conclusions: Despite the ministerial regulations restricting their use, MCI and/or MI are still found in cosmetics sold on the Thai market. Dermatologists should be aware of this situation, and counsel patients to avoid products containing MCI and/or MI.
(Less)
- author
- Sukakul, Thanisorn LU ; Kanchanapenkul, Dollaporn ; Bunyavaree, Monthathip ; Limphoka, Pichaya ; Kumpangsin, Titinun and Boonchai, Waranya
- publishing date
- 2019-02
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- cosmetics, ingredient labelling, isothiazolinones, methylchloroisothiazolinone, methylisothiazolinone, skin-care products
- in
- Contact Dermatitis
- volume
- 80
- issue
- 2
- pages
- 110 - 113
- publisher
- Wiley-Blackwell
- external identifiers
-
- scopus:85056611052
- pmid:30426516
- ISSN
- 0105-1873
- DOI
- 10.1111/cod.13151
- language
- English
- LU publication?
- no
- additional info
- Publisher Copyright: © 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
- id
- 9698923a-74ef-4eb0-9dc4-25bb7808ad59
- date added to LUP
- 2024-07-15 14:35:00
- date last changed
- 2024-07-17 02:17:05
@article{9698923a-74ef-4eb0-9dc4-25bb7808ad59, abstract = {{<p>Background: There was a global epidemic of methylchloroisothiazolinone (MCI) and/or methylisothiazolinone (MI) contact allergy from 2009 to 2015. In response, the Thai Ministry of Public Health regulated the use of MCI/MI in cosmetics. Objective: To survey the presence of MCI/MI and MI alone, as labelled on cosmetics sold on the Thai market, before and after the ministerial directive. Methods: The presence of MCI and/or MI in leave-on and rinse-off cosmetics sold on the market, based on the labelling of ingredients in 3445 products, was analysed. Results: Before the implementation date, most leave-on products contained MCI/MI. After the regulations came into force, the only leave-on cosmetic subcategories that complied with the law were facial skin-care, sunscreen and make-up products. MCI/MI and MI alone were found on the labels of both leave-on and rinse-off products, the presence of each varying between product subcategories. Conclusions: Despite the ministerial regulations restricting their use, MCI and/or MI are still found in cosmetics sold on the Thai market. Dermatologists should be aware of this situation, and counsel patients to avoid products containing MCI and/or MI.</p>}}, author = {{Sukakul, Thanisorn and Kanchanapenkul, Dollaporn and Bunyavaree, Monthathip and Limphoka, Pichaya and Kumpangsin, Titinun and Boonchai, Waranya}}, issn = {{0105-1873}}, keywords = {{cosmetics; ingredient labelling; isothiazolinones; methylchloroisothiazolinone; methylisothiazolinone; skin-care products}}, language = {{eng}}, number = {{2}}, pages = {{110--113}}, publisher = {{Wiley-Blackwell}}, series = {{Contact Dermatitis}}, title = {{Methylchloroisothiazolinone and/or methylisothiazolinone in cosmetic products—A market survey}}, url = {{http://dx.doi.org/10.1111/cod.13151}}, doi = {{10.1111/cod.13151}}, volume = {{80}}, year = {{2019}}, }